https://www.pharmanow.live/latest-news/viatris-tender-offer-acquire-pacira-biosciences 2026-10-30T22:21:24+05:30 Pharma Now en 2026-10-30T00:00:00+05:30 Viatris Launches Tender Offer to Acquire Pacira BioSciences for $36.50 Per Share Viatris https://pharmanow.nyc3.cdn.digitaloceanspaces.com/https://newsroom.viatris.com/file.php/181193/Refreshed_Viatris_Logo_thumb.png?thumbnail=144 https://www.pharmanow.live/latest-news/ema-prac-immunoglobulin-hypersensitivity-batch-review-2026 2026-10-30T22:20:38+05:30 Pharma Now en 2026-10-30T00:00:00+05:30 EMA PRAC Launches Class-Wide Review of Human Normal Immunoglobulins EMA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/598c6d02-5da0-4c1d-abdd-424650de43b8/228592f9-8375-403a-ad65-c5cc8b77c767.png https://www.pharmanow.live/latest-news/fda-risk-based-inspection-model-cgmp-compliance-drug-manufacturing 2026-10-30T22:17:11+05:30 Pharma Now en 2026-10-30T00:00:00+05:30 FDA Reinforces Risk-Based Inspection Model Across All U.S. Drug Manufacturing Sites FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/68750825-0b20-441b-a564-e1242f5a1283/3bc53589-71de-4e87-b905-c357be4f6c6f.png https://www.pharmanow.live/latest-news/fda-frame-amtdp-continuous-manufacturing-ai-regulatory-framework 2026-10-30T22:23:59+05:30 Pharma Now en 2026-10-30T00:00:00+05:30 FDA Advances FRAME and AMTDP to Regulate Continuous, AI-Driven Drug Manufacturing FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/68750825-0b20-441b-a564-e1242f5a1283/0f320e60-64d1-418e-b521-e4c1accd2cb6.png https://www.pharmanow.live/latest-news/celularity-vesalius-longevity-labs-exclusive-peptide-api-manufacturing-deal 2026-10-30T22:26:10+05:30 Pharma Now en 2026-10-30T00:00:00+05:30 Celularity Signs Exclusive Deal with Vesalius Longevity Labs Celularity https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/058161f1-bc77-4e56-90a6-0fed6544c64b/f8c0a150-65aa-4006-bfa7-46d30e4fd194.png https://www.pharmanow.live/latest-news/fda-ectd-v4-sample-submission-pathway-technical-filing-errors 2026-10-30T12:10:15+05:30 Pharma Now en 2026-10-29T00:00:00+05:30 FDA Opens eCTD v4.0 Sample Submission Pathway for Drug Sponsors FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/fda-ectd-v4-sample-submission-pathway-technical-validation-filing-errors-202620261030120913.webp https://www.pharmanow.live/latest-news/fda-draft-guidance-drug-delivery-performance-characteristics-combination-products 2026-10-30T12:06:51+05:30 Pharma Now en 2026-10-29T00:00:00+05:30 FDA Draft Guidance Sets Drug Delivery Data Standards FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/fda-drug-delivery-performance-combination-products-draft-guidance-202620261030113559.webp https://www.pharmanow.live/latest-news/fda-ectd-v4-forward-compatibility-october-2026 2026-10-30T11:31:15+05:30 Pharma Now en 2026-10-29T00:00:00+05:30 FDA Activates eCTD v4.0 Forward Compatibility for Drug Filings FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/fda-ectd-v4-forward-compatibility-drug-submissions-october-202620261030113014.webp https://www.pharmanow.live/latest-news/insmed-fda-priority-review-arikayce-snda-japan-brinsupri-ncfb-approval 2026-10-30T11:27:44+05:30 Pharma Now en 2026-10-29T00:00:00+05:30 Insmed Gains FDA Priority Review for ARIKAYCE sNDA Insmed https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/insmed-arikayce-fda-priority-review-brinsupri-japan-launch-202620261030112728.webp https://www.pharmanow.live/latest-news/fda-confirms-rx7-articulaciones-hidden-diclofenac-dexamethasone 2026-10-30T11:23:43+05:30 Pharma Now en 2026-10-29T00:00:00+05:30 FDA Confirms RX7 Articulaciones Contains Undeclared Drugs FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/fda-rx7-articulaciones-hidden-diclofenac-dexamethasone-202620261030112244.webp https://www.pharmanow.live/latest-news/fda-confirms-ort-flx-undeclared-diclofenac-dexamethasone-methocarbamol 2026-10-30T11:11:44+05:30 Pharma Now en 2026-10-29T00:00:00+05:30 FDA Confirms Three Undeclared Drugs in Ort-Flx Pain Product FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/fda-ort-flx-undeclared-diclofenac-dexamethasone-methocarbamol-202620261030111001.webp https://www.pharmanow.live/latest-news/azora-therapeutics-appoints-executive-team-at177-phase-1-ulcerative-colitis-2027 2026-10-30T11:03:10+05:30 Pharma Now en 2026-10-29T00:00:00+05:30 Azora Therapeutics Appoints New Executive Team to Advance AT177 Azora https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/azora-therapeutics-executive-team-at177-ulcerative-colitis-phase-1-202720261030110132.webp https://www.pharmanow.live/latest-news/fda-biosimilar-approval-tracker-2024-2026 2026-10-30T10:49:15+05:30 Pharma Now en 2026-10-29T00:00:00+05:30 FDA Biosimilar Tracker: 30+ Products Cleared Since Mid-2024 FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/fda-biosimilar-approval-tracker-2024-2026-30-plus-products20261030104748.webp